Encapsulation of Thymol in Gelatin Methacryloyl (GelMa)-Based Nanoniosome Enables Enhanced Antibiofilm Activity and Wound Healing
Pharmaceutics · 09.06.2023 · 15 (6) · 1699
DOI: 10.3390/pharmaceutics15061699 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 09.06.2023. Verfasst von Maryam Moghtaderi und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical Engineering, College of Engineering, University of Tehran, Tehran 1417935840, Iran. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Wundversorgung
Abstract (Originalsprache)
Non-healing wounds impose huge cost on patients, healthcare, and society, which are further fortified by biofilm formation and antimicrobial resistance (AMR) problems. Here, Thymol, an herbal antimicrobial agent, is utilized to combat AMR. For efficient delivery of Thymol gelatin methacryloyl (GelMa), a hydrophilic polymeric hydrogel with excellent biocompatibility combined with niosome was used to encapsulate Thymol. After optimization of the niosomal Thymol (Nio–Thymol) in the company of GelMa (Nio–Thymol@GelMa) to achieve maximum entrapment efficiency, minimum size, and low polydispersity index, the Thymol release peaked at 60% and 42% from Nio–Thymol@GelMa in medium with pH values of 6.5 and 7.4 after 72 h, respectively. Furthermore, Nio–Thymol@GelMa demonstrated higher antibacterial and anti-biofilm activity than Nio–Thymol and free Thymol against both Gram-negative and Gram-positive bacteria. Interestingly, compared with other obtained formulations, Nio–Thymol@GelMa also led to greater enhancement of migration of human dermal fibroblasts in vitro, and higher upregulation of the expression of certain growth factors such as FGF-1, and matrix metalloproteinases such as MMP-2 and MMP-13. These results suggest that Nio–Thymol@GelMa can represent a potential drug preparation for Thymol to enhance the wound healing process and antibacterial efficacy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Chemical Engineering, College of Engineering, University of Tehran, Tehran 1417935840, Iran.
- Department of Community Medicine, Mashhad Branch, Islamic Azad University, Mashhad 1477893855, Iran.
- Department of Molecular and Cellular Biology, Faculty of Advance Sciences and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran 1477893855, Iran.
- Department of Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran 1517964311, Iran.
- Laboratory for Biointerfaces, Empa, Swiss Federal Laboratories for Materials Science and Technology, 9014 St. Gallen, Switzerland.
ORCID-Profile: Qun Ren
Zitieren
APA
Moghtaderi, M., Bazzazan, S., Sorourian, G., Sorourian, M., Akhavanzanjani, Y., Noorbazargan, H., & Ren, Q. (2023). Encapsulation of Thymol in Gelatin Methacryloyl (GelMa)-Based Nanoniosome Enables Enhanced Antibiofilm Activity and Wound Healing. Pharmaceutics, 15(6), 1699. https://doi.org/10.3390/pharmaceutics15061699
Vancouver
Moghtaderi M, Bazzazan S, Sorourian G, Sorourian M, Akhavanzanjani Y, Noorbazargan H, et al. Encapsulation of Thymol in Gelatin Methacryloyl (GelMa)-Based Nanoniosome Enables Enhanced Antibiofilm Activity and Wound Healing. Pharmaceutics. 2023;15(6):1699. doi:10.3390/pharmaceutics15061699
BibTeX
@article{Moghtaderi2023,
author = {Moghtaderi, Maryam and Bazzazan, Saba and Sorourian, Ghazal and Sorourian, Maral and Akhavanzanjani, Yasaman and Noorbazargan, Hassan and Ren, Qun},
title = {Encapsulation of Thymol in Gelatin Methacryloyl (GelMa)-Based Nanoniosome Enables Enhanced Antibiofilm Activity and Wound Healing},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {6},
pages = {1699},
doi = {10.3390/pharmaceutics15061699}
}
EUVIMED